AI reveals insights into link between CD33 and cognitive impairment in Alzheimer's Disease.

Modeling biological mechanisms is a key for disease understanding and drug-target identification. However, formulating quantitative models in the field of Alzheimer's Disease is challenged by a lack of detailed knowledge of relevant biochemical processes. Additionally, fitting differential equa...

Full description

Bibliographic Details

Published in:	PLoS Computational Biology
Main Authors:	Tamara Raschka, Meemansa Sood, Bruce Schultz, Aybuge Altay, Christian Ebeling, Holger Fröhlich
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2023-02-01
Online Access:	https://doi.org/10.1371/journal.pcbi.1009894